uniQure N.V.

QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590560

Price chart

Open-market purchases and sales by QURE insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jul 7, 20264:47 PM ETJul 2, 2026Kapusta Matthew CCEO, Managing DirectorSSaleOrdinary Shares−21.08K$45.1594−$952.05K519.23K−3.9%SEC10b5-1
Jul 2, 20264:59 PM ETJun 30, 2026Abi-Saab WalidChief Medical OfficerSSaleOrdinary Shares−30K$46.42−$1.39M148.24K−16.8%SEC10b5-1
Jul 2, 20264:54 PM ETJun 30, 2026Kaye JackDirectorSSaleOrdinary Shares−21.17K$46.4416−$983.03K26K−44.9%SEC10b5-1
Jun 30, 2026Jun 26, 2026Abi-Saab WalidChief Medical OfficerSSaleOrdinary Shares−1.43K$46.86−$67.2K168.24K−0.8%SEC
Jun 26, 2026Jun 24 – Jun 25, 2026Kapusta Matthew CCEO, Managing DirectorSSaleOrdinary Shares−35.41K$50.0162−$1.77M519.23K−6.4%SEC10b5-1

The largest institutional positions in QURE at the end of Q2 2026.

Institutions holding QURE in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Avoro Capital Advisors LLC6,727,777$309.88M2.78%+768,182+12.9%Added
JPMORGAN CHASE & CO4,867,755$230.81M0.01%+2,030,289+71.6%Added
RTW INVESTMENTS, LP3,941,572$181.55M1.55%+1,355,216+52.4%Added
STATE STREET CORP2,903,825$133.75M0.00%+643,313+28.5%Added
Standard Life Aberdeen plc2,848,117$131.18M0.18%−2,458,269−46.3%Reduced